Evidence map›Paper›PMID 32923874›Full record

ArticleJCO precision oncology2020

Neuroendocrine Tumors Are Enriched in Cowden Syndrome.

Alison Greidinger, Susan Miller-Samuel, Veda N Giri, Michele Sue-Ann Woo, Saranya Akumalla, Charnita Zeigler-Johnson, Scott W Keith, Daniel P Silver

Open access · greenAbstract readCase Reports
In one paragraph

Article in JCO precision oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Sinonasal Neuroendocrine Carcinoma in Adult Proteus Syndrome.Iranian journal of otorhinolaryngology · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alison GreidingerDepartment of Medicine, Thomas Jefferson University, Philadelphia, PA.
Susan Miller-SamuelCancer Risk Assessment and Clinical Cancer Genetics Program, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Veda N GiriDepartment of Medical Oncology and Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Michele Sue-Ann WooFoundation Medicine, Cambridge, MA.
Saranya AkumallaFoundation Medicine, Cambridge, MA.
Charnita Zeigler-JohnsonDepartment of Medical Oncology, Thomas Jefferson University, Philadelphia, PA.
Scott W KeithDepartment of Pharmacology and Experimental Therapeutics, Division of Biostatistics, Thomas Jefferson University, Philadelphia, PA.
Daniel P SilverDepartment of Medical Oncology and Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Thomas Jefferson University · USFoundation Medicine (United States)Sidney Kimmel Cancer Center · US

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI DANIEL P SILVER · 1995 to 2026
$94.8M
NCI NIH HHS P30 CA056036
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32923874
PMCPMC7446357
OpenAlexW3032750592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.